Risk-Based Breast Screening: Why One Schedule May Not Fit Everyone

Risk is not one number

The figure most people have heard is about 1 in 8 over a lifetime. NCI's recent estimates cluster near that, ranging from 12.32 to 12.83 percent across five reporting periods.

That number describes a whole population over a whole life. It is a poor guide to any single decade.

NCI's shorter-range estimates are more useful. The chance of being diagnosed with breast cancer in the next 10 years, starting at a given age, is:

• Age 30: about 0.49 percent, or 1 in 204.
• Age 40: about 1.55 percent, or 1 in 65.
• Age 50: about 2.40 percent, or 1 in 42.
• Age 60: about 3.54 percent, or 1 in 28.
• Age 70: about 4.09 percent, or 1 in 24.

The risk at 70 is roughly eight times the risk at 30. That spread is the reason anyone raises the idea of tailoring a schedule.

What "risk-based" would mean

The idea is straightforward. Estimate a person's risk. Then set how often they are screened, starting at what age, and with which test.

NCI notes that health professionals can use the Breast Cancer Risk Assessment Tool, which draws on several known risk factors. Age, family history, previous biopsies, and reproductive history all feed such estimates.

Two cautions belong with that. NCI says an individual's risk may be higher or lower depending on known factors and on factors that are not yet fully understood. And a risk score is a probability, not a forecast for one person.

The harms are not hypothetical

Screening finds cancers earlier, and earlier treatment can be more effective. NCI states both the benefit and the harms.

False-positive results. These cause distress and lead to more imaging and biopsies, which carry their own harm. NCI notes they are more common in younger women, women with dense breasts, women with previous biopsies, women with a family history, and women taking estrogen.

Overdiagnosis and overtreatment. Some cancers found by screening would never have caused problems in a person's lifetime. Finding them earlier may not help someone live longer, but it does expose them to treatment.

Screening less often could miss cancers. Screening more often adds false alarms and overdiagnosis. There is no setting that removes both.

Where extra tests fit, and where the evidence stops

MRI is more sensitive than mammography and may be added for women at high risk, since mammography alone can miss some cancers in that group.

For dense breasts, NCI is careful. MRI or ultrasound may be offered in addition to mammography. But it is not known whether that extra screening leads to better health outcomes. More detection is not automatically more benefit.

If you have been told your breasts are dense, our page on what to ask after a dense-breast notice covers the conversation.

Two tests are not adequate on their own: a clinical breast exam alone, and breast self-exam alone. Knowing how your breasts normally feel still matters, and any unusual change should be reported even after a normal mammogram.

Where things stand today

Risk-based schedules are being studied. They are not the current standard. Today's decisions rest on age, validated risk factors, and existing guidance, worked out with a clinician who knows your history.

Ask before the next mammogram

• What is my estimated risk, and what tool produced it?
• Which of my risk factors actually moved that number?
• What schedule do you recommend, and why that one?
• What happens if a result is unclear?
• What are the harms of screening more often in my case?

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.